Etomidate


Generic Medicine Info
Special Precautions
Patient w/ cortico-adrenal insufficiency (e.g. patient w/ sepsis), pre-existing epilepsy, hepatic cirrhosis. Renal impairment. Elderly and childn. Pregnancy and lactation. Patient Counselling May impair ability to drive or operate machinery. Monitoring Parameters Monitor BP, renal function, CV or resp status, signs of adrenal insufficiency.
Adverse Reactions
Excitatory phenomena e.g. myoclonus; pain on inj site; hyperventilation, hypoventilation, apnoea, hiccups and snoring, HTN, hypotension, postoperative nausea and vomiting. Rarely, convulsions, cardiac arrhythmias, laryngospasm.
Drug Interactions
Increased hypnotic effect when used w/ neuroleptic drugs, opioids and sedatives. May enhance the effect of hypotensive drugs.
ATC Classification
N01AX07 - etomidate ; Belongs to the class of other general anesthetics.
Disclaimer: This information is independently developed by CIMS based on etomidate from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in